SPATA7: Potential Drug Target Or Biomarker for Prostate-Related Conditions

Target Name: SPATA7

NCBI ID: G55812

SPATA7

SPATA7: Potential Drug Target Or Biomarker for Prostate-Related Conditions

SPATA7 (secretory protein Li 296) is a protein that is expressed in the epithelial cells of the prostate gland, and it is involved in the regulation of various physiological processes that are important for maintaining the health and function of the prostate gland. Several studies have suggested that SPATA7 may have potential as a drug target or biomarker for various prostate-related conditions, and further research is needed to confirm these findings.

SPATA7 is a member of the SPATA gene family, which is known for producing proteins that are involved in the regulation of cell signaling pathways. The SPATA gene family has been identified as a potential therapeutic target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of SPATA7 is its role in the regulation of prostate-related signaling pathways. The prostate gland is a complex system that is responsible for the production and storage of fluids, including semen. The normal function of the prostate gland is dependent on the regulation of various signaling pathways, including those that are involved in cell growth, differentiation, and survival. SPATA7 is involved in the regulation of these signaling pathways, and its absence or dysfunction has been implicated in the development and progression of various prostate-related conditions.

SPATA7 is also involved in the regulation of the balance of ion channels in epithelial cells. These channels are responsible for the flow of ions and play a crucial role in maintaining the electrical properties of the epithelial cells. The regulation of ion channels is critical for the proper functioning of epithelial cells, and alterations in this regulation have been implicated in the development of various prostate-related conditions.

In addition to its role in cell signaling pathways, SPATA7 is also involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues, and it is a critical factor in the development and maintenance of various tissues and organs. The regulation of cell adhesion is critical for the proper functioning of tissues and organs, and alterations in this regulation have been implicated in the development of various diseases.

SPATA7 has also been shown to be involved in the regulation of cell cycle progression. The cell cycle is the process by which cells grow and divide, and it is a critical factor in the development and maintenance of various tissues and organs. The regulation of cell cycle progression is critical for the proper functioning of cells, and alterations in this regulation have been implicated in the development and progression of various diseases.

In conclusion, SPATA7 is a protein that is involved in the regulation of various physiological processes that are important for maintaining the health and function of the prostate gland. Its absence or dysfunction has been implicated in the development and progression of various prostate-related conditions, and further research is needed to confirm these findings. Further research is also needed to determine the full range of functions of SPATA7 as a drug target or biomarker.

Protein Name: Spermatogenesis Associated 7

Functions: Involved in the maintenance of both rod and cone photoreceptor cells (By similarity). It is required for recruitment and proper localization of RPGRIP1 to the photoreceptor connecting cilium (CC), as well as photoreceptor-specific localization of proximal CC proteins at the distal CC (By similarity). Maintenance of protein localization at the photoreceptor-specific distal CC is essential for normal microtubule stability and to prevent photoreceptor degeneration (By similarity)

The "SPATA7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets